Implementation in action : Collaborating on the transition to primary HPV screening for cervical cancer in the United States
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
CA: a cancer journal for clinicians - 73(2023), 5 vom: 01. Sept., Seite 458-460 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Downs, Levi S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cervical neoplasms |
|---|
| Anmerkungen: |
Date Completed 02.11.2023 Date Revised 07.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3322/caac.21786 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358494109 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358494109 | ||
| 003 | DE-627 | ||
| 005 | 20231226074847.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3322/caac.21786 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358494109 | ||
| 035 | |a (NLM)37347977 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Downs, Levi S |c Jr |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Implementation in action |b Collaborating on the transition to primary HPV screening for cervical cancer in the United States |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.11.2023 | ||
| 500 | |a Date Revised 07.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cervical neoplasms | |
| 650 | 4 | |a cytopathology or cytotechnology | |
| 650 | 4 | |a gynecologic oncology | |
| 650 | 4 | |a obstetrics and gynecology | |
| 650 | 4 | |a prevention | |
| 700 | 1 | |a Nayar, Ritu |e verfasserin |4 aut | |
| 700 | 1 | |a Gerndt, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Saslow, Debbie |e verfasserin |4 aut | |
| 700 | 0 | |a American Cancer Society Primary HPV Screening Initiative Steering Committee |e verfasserin |4 aut | |
| 700 | 1 | |a Arrindell, Deborah |e investigator |4 oth | |
| 700 | 1 | |a Feldman, Sarah |e investigator |4 oth | |
| 700 | 1 | |a Franco, Eduardo L |e investigator |4 oth | |
| 700 | 1 | |a García, Francisco |e investigator |4 oth | |
| 700 | 1 | |a Lind, Eileen |e investigator |4 oth | |
| 700 | 1 | |a Lorey, Thomas S |e investigator |4 oth | |
| 700 | 1 | |a MacLaughlin, Kathy L |e investigator |4 oth | |
| 700 | 1 | |a Marcus, Jenna Z |e investigator |4 oth | |
| 700 | 1 | |a Novetsky, Akiva P |e investigator |4 oth | |
| 700 | 1 | |a Perkins, Rebecca B |e investigator |4 oth | |
| 700 | 1 | |a Saraiya, Mona |e investigator |4 oth | |
| 700 | 1 | |a Satterfield, Lisa |e investigator |4 oth | |
| 700 | 1 | |a Smith, Robert A |e investigator |4 oth | |
| 700 | 1 | |a Waxman, Alan G |e investigator |4 oth | |
| 700 | 1 | |a Wentzensen, Nicolas |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t CA: a cancer journal for clinicians |d 1957 |g 73(2023), 5 vom: 01. Sept., Seite 458-460 |w (DE-627)NLM000381551 |x 1542-4863 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2023 |g number:5 |g day:01 |g month:09 |g pages:458-460 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3322/caac.21786 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2023 |e 5 |b 01 |c 09 |h 458-460 | ||